Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121224805 | 12122480 | 5 | F | 20160206 | 20160624 | 20160226 | 20160812 | EXP | CN-ASTRAZENECA-2016SE17931 | ASTRAZENECA | 19001.00 | DY | F | Y | 0.00000 | 20160812 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121224805 | 12122480 | 1 | PS | AZD2281 | OLAPARIB | 1 | Oral | 0 | 100 | MG | TABLET | BID | |||||||
| 121224805 | 12122480 | 2 | SS | AZD2281 | OLAPARIB | 1 | Oral | 0 | 100 | MG | TABLET | BID | |||||||
| 121224805 | 12122480 | 3 | SS | AZD2281 | OLAPARIB | 1 | Oral | 0 | 100 | MG | TABLET | BID | |||||||
| 121224805 | 12122480 | 4 | SS | AZD2281 | OLAPARIB | 1 | Oral | 0 | 100 | MG | TABLET | BID | |||||||
| 121224805 | 12122480 | 5 | SS | AZD2281 | OLAPARIB | 1 | Oral | 0 | 100 | MG | TABLET | BID | |||||||
| 121224805 | 12122480 | 6 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 80MG/M2 AS IN IV INFUSION OVER 1 HOUR | 0 | INTRAVENOUS INFUSION | |||||||||
| 121224805 | 12122480 | 7 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 80MG/M2 AS IN IV INFUSION OVER 1 HOUR | 0 | INTRAVENOUS INFUSION | |||||||||
| 121224805 | 12122480 | 8 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 80MG/M2 AS IN IV INFUSION OVER 1 HOUR | 0 | INTRAVENOUS INFUSION | |||||||||
| 121224805 | 12122480 | 9 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 80MG/M2 AS IN IV INFUSION OVER 1 HOUR | 0 | INTRAVENOUS INFUSION | |||||||||
| 121224805 | 12122480 | 10 | C | DACHAIHU GRANULATION | 2 | Oral | 0 | 8 | G | GRANULES | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121224805 | 12122480 | 1 | Neoplasm |
| 121224805 | 12122480 | 2 | Neoplasm |
| 121224805 | 12122480 | 3 | Neoplasm |
| 121224805 | 12122480 | 4 | Neoplasm |
| 121224805 | 12122480 | 5 | Neoplasm |
| 121224805 | 12122480 | 6 | Neoplasm |
| 121224805 | 12122480 | 7 | Neoplasm |
| 121224805 | 12122480 | 8 | Neoplasm |
| 121224805 | 12122480 | 9 | Neoplasm |
| 121224805 | 12122480 | 10 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121224805 | 12122480 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121224805 | 12122480 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121224805 | 12122480 | 1 | 20160120 | 20160120 | 0 | |
| 121224805 | 12122480 | 2 | 20160123 | 20160130 | 0 | |
| 121224805 | 12122480 | 3 | 20160131 | 20160215 | 0 | |
| 121224805 | 12122480 | 4 | 20160216 | 20160330 | 0 | |
| 121224805 | 12122480 | 5 | 20160401 | 20160401 | 0 | |
| 121224805 | 12122480 | 6 | 20160131 | 20160131 | 0 | |
| 121224805 | 12122480 | 7 | 20160206 | 20160206 | 0 | |
| 121224805 | 12122480 | 8 | 20160215 | 20160215 | 0 | |
| 121224805 | 12122480 | 9 | 20160308 | 20160321 | 0 | |
| 121224805 | 12122480 | 10 | 20160206 | 0 |